Literature DB >> 3323902

Aerobic glucose fermentation by Trypanosoma cruzi axenic culture amastigote-like forms during growth and differentiation to epimastigotes.

J C Engel1, B M Franke de Cazzulo, A O Stoppani, J J Cannata, J J Cazzulo.   

Abstract

Axenic culture amastigote-like forms of Trypanosoma cruzi, grown at 28 degrees C, reach a stationary phase after two generations, and differentiate to epimastigotes, which then resume growth. Axenic culture amastigotes readily ferment glucose to succinate and acetate, and do not excrete NH3; they have high activities of hexokinase and phosphoenolpyruvate carboxykinase, and very low citrate synthase activity; cytochrome o is absent, and cytochrome b-like is present at a very low level. Epimastigotes catabolize glucose and produce succinate and acetate at a considerably lower rate; they exhibit lower levels of hexokinase and carboxykinase, and much higher levels of citrate synthase and cytochromes o and b-like. They catabolize amino acids, as shown by excretion of NH3 to the medium. The results suggest that axenic culture amastigotes have an essentially glycolytic metabolism, and they acquire the ability to oxidize substrates such as amino acids only after differentiation to epimastigotes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323902     DOI: 10.1016/0166-6851(87)90123-x

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  20 in total

1.  Stationary phase in Trypanosoma cruzi epimastigotes as a preadaptive stage for metacyclogenesis.

Authors:  Roberto Hernández; Ana María Cevallos; Tomás Nepomuceno-Mejía; Imelda López-Villaseñor
Journal:  Parasitol Res       Date:  2012-05-31       Impact factor: 2.289

2.  Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.

Authors:  A M Aronov; S Suresh; F S Buckner; W C Van Voorhis; C L Verlinde; F R Opperdoes; W G Hol; M H Gelb
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

3.  A nonazole CYP51 inhibitor cures Chagas' disease in a mouse model of acute infection.

Authors:  Patricia S Doyle; Chiung-Kuang Chen; Jonathan B Johnston; Stephanie D Hopkins; Siegfried S F Leung; Matthew P Jacobson; Juan C Engel; James H McKerrow; Larissa M Podust
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

4.  Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.

Authors:  J C Bressi; C L Verlinde; A M Aronov; M L Shaw; S S Shin; L N Nguyen; S Suresh; F S Buckner; W C Van Voorhis; I D Kuntz; W G Hol; M H Gelb
Journal:  J Med Chem       Date:  2001-06-21       Impact factor: 7.446

5.  In silico prediction of a new lead compound targeting enolase of trypanosomatids through structure-based virtual screening and molecular dynamic studies.

Authors:  V M Vidhya; B S Lakshmi; Karthe Ponnuraj
Journal:  J Mol Model       Date:  2020-01-07       Impact factor: 1.810

Review 6.  Tryp-ing Up Metabolism: Role of Metabolic Adaptations in Kinetoplastid Disease Pathogenesis.

Authors:  Adwaita R Parab; Laura-Isobel McCall
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

7.  Metabolomic profiling reveals a finely tuned, starvation-induced metabolic switch in Trypanosoma cruzi epimastigotes.

Authors:  María Julia Barisón; Ludmila Nakamura Rapado; Emilio F Merino; Elizabeth Mieko Furusho Pral; Brian Suarez Mantilla; Letícia Marchese; Cristina Nowicki; Ariel Mariano Silber; Maria Belen Cassera
Journal:  J Biol Chem       Date:  2017-03-29       Impact factor: 5.157

8.  Enolase: a key player in the metabolism and a probable virulence factor of trypanosomatid parasites-perspectives for its use as a therapeutic target.

Authors:  Luisana Avilán; Melisa Gualdrón-López; Wilfredo Quiñones; Limari González-González; Véronique Hannaert; Paul A M Michels; Juan-Luis Concepción
Journal:  Enzyme Res       Date:  2011-04-07

9.  Structure-based approach to the identification of a novel group of selective glucosamine analogue inhibitors of Trypanosoma cruzi glucokinase.

Authors:  Edward L D'Antonio; Mason S Deinema; Sean P Kearns; Tyler A Frey; Scott Tanghe; Kay Perry; Timothy A Roy; Hanna S Gracz; Ana Rodriguez; Jennifer D'Antonio
Journal:  Mol Biochem Parasitol       Date:  2016-01-14       Impact factor: 1.759

10.  The active transport of histidine and its role in ATP production in Trypanosoma cruzi.

Authors:  M J Barisón; F S Damasceno; B S Mantilla; A M Silber
Journal:  J Bioenerg Biomembr       Date:  2016-05-24       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.